Fig. 1From: Optimising recruitment in clinical trials for progressive multiple sclerosis: observational analysis from the MS-SMART and MS-STAT2 randomised controlled trialsParticipant recruitment and reasons for ineligibility at the lead UCL site for MS-SMART. *As this data is derived from the lead UCL MS-SMART site only, this number (237 participants attending screening) differs from the total number of participants screened across all UK sites (547), which is reported in reference [9]. RRMS, relapsing remitting multiple sclerosis; PPMS, primary progressive multiple sclerosis; EDSS, Expanded Disability Status ScaleBack to article page